Effect of CYP2C9-VKORC1 interaction on warfarin stable dosage and its predictive algorithm

J Clin Pharmacol. 2015 Mar;55(3):251-7. doi: 10.1002/jcph.392. Epub 2014 Sep 16.

Abstract

This study aimed to identify the effect of CYP2C9-VKORC1 interaction on warfarin dosage requirement and its predictive algorithm by investigating four populations. Generalized linear model was used to evaluate the relationship between the interaction and warfarin stable dosage (WSD), whereas multiple linear regression analysis was applied to construct the WSD predictive algorithm. To evaluate the effect of CYP2C9-VKORC1 interaction on the predictive algorithms, we compared the algorithms with and without the interaction. The interaction was significantly associated with WSD in the Chinese and White cohorts (P values < 0.05). In the algorithms that considered the interaction, the predictive success rates improved by only 0.12% in the Chinese patients and by a maximum of 0.02% in the White patients under four different CYP2C9 classifications. Thus, VKORC1-CYP2C9 interaction can affect WSD. However, the discrepancy between the predictive results obtained using the predictive algorithm with and without CYP2C9-VKORC1 interaction was negligible and can therefore be disregarded.

Keywords: algorithms; epistasis; racial difference; single nucleotide polymorphism; warfarin.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Algorithms*
  • Anticoagulants / administration & dosage*
  • Anticoagulants / adverse effects
  • Anticoagulants / pharmacokinetics
  • Asian People / genetics
  • Black People / genetics
  • Blood Coagulation / drug effects*
  • Chi-Square Distribution
  • Child
  • Cytochrome P-450 CYP2C9 / genetics*
  • Cytochrome P-450 CYP2C9 / metabolism
  • Drug Dosage Calculations*
  • Drug Monitoring / methods
  • Female
  • Gene Frequency
  • Genotype
  • Humans
  • International Normalized Ratio
  • Linear Models
  • Male
  • Middle Aged
  • Models, Biological
  • Pharmacogenetics*
  • Phenotype
  • Risk Factors
  • Vitamin K Epoxide Reductases / genetics*
  • Vitamin K Epoxide Reductases / metabolism
  • Warfarin / administration & dosage*
  • Warfarin / adverse effects
  • Warfarin / pharmacokinetics
  • White People / genetics
  • Young Adult

Substances

  • Anticoagulants
  • Warfarin
  • CYP2C9 protein, human
  • Cytochrome P-450 CYP2C9
  • VKORC1 protein, human
  • Vitamin K Epoxide Reductases